Moderna Inc
NASDAQ: MRNA
$108.85
+$0.96 (+0.9%)
Closing price April 24, 2024
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Published:
2018 was one of the last full years we would feel normal as a world for a long time. We had no idea what was hurling around the corner. That year, Drake led the charts with “God’s Plan” and...
Published:
U.S. stocks are adding to Wednesday's comeback with solid gains after about half an hour of trading Thursday morning. Here are winners and losers.
Published:
Pfizer stock has tumbled due to shrinking vaccine sales and the potential for a social and consumer backlash. Moderna stock has also been pounded.
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
Published:
Friday's top analyst upgrades and downgrades included DXC Technology, Etsy, Extreme Networks, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines,...
Published:
Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla, Under Armour, Ventas, Viatris,...
Published:
Tuesday's top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto Networks, Snap, Uber Technologies and Wells...
Published:
Wednesday morning's report on the consumer price index likely will set the direction for stock traders. But there are some outliers.
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published:
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Apple, Array Technologies, CarMax, Coupang, Discover Financial Services, Intel, Kohl's, Marvell Technology, Moderna, Nio,...
Published:
Monday's top analyst upgrades and downgrades included Block, Broadcom, CarMax, Deere, Esperion Therapeutics, Marvell Technology, MGM Resorts International, Moderna, Newmont, Vipshop and Wingstop.
Published:
U.S. markets closed mixed on Tuesday and traded slightly higher Wednesday morning, ahead of reports on the producer price index and retail sales.
Published: